Robert Schultz
Corporate Officer/Principal bij SATSUMA PHARMACEUTICALS, INC.
Profiel
Robert Schultz is currently the Vice President & Head-CMC at Satsuma Pharmaceuticals, Inc. Prior to this, he worked at Pearl Therapeutics, Inc. as the Senior Director-Product Development from 2012 to 2017.
He also worked as a Principal at Muro Corp., KOS*USA, Inc., and GlaxoSmithKline (New Jersey).
Mr. Schultz completed his undergraduate degree at Dartmouth College.
Actieve functies van Robert Schultz
Bedrijven | Functie | Begin |
---|---|---|
SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2017 |
Eerdere bekende functies van Robert Schultz
Bedrijven | Functie | Einde |
---|---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01-07-2017 |
GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | - |
KOS*USA, Inc.
KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
MURO CORPORATION | Corporate Officer/Principal | - |
Opleiding van Robert Schultz
Dartmouth College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MURO CORPORATION | Producer Manufacturing |
Bedrijven in privébezit | 4 |
---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
KOS*USA, Inc.
KOS*USA, Inc. Apparel/FootwearConsumer Non-Durables KOS*USA, Inc. manufactures and distributes fitness apparel. It supplies tops, bodysuit, bottoms, and prints to gyms, exclusive spas, specialty stores, and boutiques. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Consumer Non-Durables |
GlaxoSmithKline (New Jersey) | |
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |